Two patients (Cases 5 and 6) underwent postoperative medical treatments, including gonadotropin-releasing hormone agonist (leuprolide acetate, 3.75 mg subcutaneously, monthly for 3 months), for the prevention of endometriosis recurrence and their postoperative serum AMH levels could not be accurately measured. The gene discussed is AMH; the disease is endometriosis.